Laserfiche WebLink
A return -to -duty test, as a minimum, will be for the substance associated with the violation. A return -to- duty test <br />may, however, be for both drugs and alcohol. The decision belongs solely to the SAP from information gained <br />during the SAP-evaluation/treatment processes. The results of a return -to -duty drug test must be negative in order <br />"to count" and allow the employee to return to work. A cancelled test must be recollected; a positive test or <br />refusal -to -test will be considered as a new, separate violation. <br />When the employee "passes" their return -to -duty test, their name is immediately placed into the Company's random <br />testing pool. <br />If the Company has a zero tolerance policy, any covered safety -sensitive employee who has a DOT drug or alcohol <br />violation will be terminated upon such violation (refer to Appendix D, Company Disciplinary Actions and Additional <br />Procedures). However, the employee will be referred to a SAP. The employee will be made aware that they must <br />complete the DOT return -to -duty process prior to again performing covered safety -sensitive work for a company that <br />is subject to the DOT alcohol and drug testing regulations. <br />Follow-up Testing. The Company will conduct follow-up testing, as a series of tests that occur after an employee <br />returns to covered safety -sensitive work, following a negative result on the return -to -duty drug and/ or alcohol tests. <br />Follow-up testing, as a minimum, will be for the substance associated with the violation. In addition, follow- <br />up testing may be for both drug and alcohol, as directed by the SAP's written follow-up testing plan. <br />Follow-up testing is the Company's responsibility to conduct. Follow-up testing will run concurrently with random <br />testing. All follow-up tests will be conducted using direct -observation collection procedures. <br />The number and frequency of the follow-up tests will be determined by the SAP, but shall consist of at least six <br />tests in the first 12 months following the covered employee's return to duty. The follow-up plan will give both the <br />number of tests and their frequency; the Company will select the actual day and time of the test and the tests are <br />unannounced. Follow-up testing shall not exceed 60 months from the date of the covered employee's return to duty. <br />The SAP may terminate the requirement for follow-up testing at any time after the first six tests have been <br />administered, if the SAP determines that such testing is no longer necessary. <br />Even if the Company has a zero tolerance policy, in the case where the Company hires an employee who previously <br />had a positive test and successfully completed the return -to -duty process and has an acceptable SAP evaluation, <br />the Company must follow the follow-up testing procedure in accordance with the DOT alcohol and drug testing <br />regulations. <br />2. Drug Tests That Require Direct Observation Procedures <br />Compliance, The Company will conduct all return -to -duty and follow-up drug tests using the direct observation <br />collection procedures specified by Part 40. Pre -employment, post -accident, reasonable suspicion/cause and <br />random drug tests are normally conducted by giving the employee the privilege of privacy when providing the urine <br />specimen. However, should it become required that these collections be conducted under direct observation <br />procedures, the Company will explain to the employee the reason(s) and convey instructions to the collector to <br />ensure that this done. Direct observation procedures will also be used for collections when a specimen is provided <br />and the temperature is out of range, when the specimen appears to have been tampered with or when a previous <br />specimen has been reported as invalid, adulterated, substituted or negative -dilute with a creatinine concentration <br />greater than or equal to 2 mg/dL but less than or equal to 5 mgrl as defined in Part 40. <br />If a service agent is aware that a directly observed collection should have been collected but was not, the service <br />agent will inform the Company to direct the employee to have an immediate recollection under observation. <br />3. Specimen Collection Procedures <br />Compliance. The Company will follow the requirements of Part 40 for its DOT collections. A full description <br />of DOT collection requirements that collectors will follow can be found in Part 40, Subpart C ("Urine Collection <br />Personnel"), and Subpart D ("Collection Sites, Forms, Equipment and Supplies Used in a DOT Urine Collection"), <br />and Subpart E ("Urine Specimen Collections"). <br />Premium Concrete Services, Inc.- PHMSA DRUG/ALCOHOL PLAN 21 <br />«) NATIONAL COMPLIANCE MANAGEMENT SERVICE, INC. (NCMS) 2011 (update 2021). The NCMS plan is <br />the subject of a registered copyright and Is protected by copyright talus in trip U.S. and elsewhere All rights <br />reserved <br />